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Myxomatous mitral valve disease (MMVD) is one of the most common acquired diseases of the cardiovascular 
system of genetic etiology in small breed dogs. A long asymptomatic course characterizes the disease. Presently, 
the main diagnostic technique for heart diseases is echocardiography. This study evaluates individual echocardio-
graphic indices of the left atrial and ventricular morphology with the determination of the diagnostic value of each 
of them in predicting the course of the disease. The study was conducted in a private veterinary hospital “Eurovet” 
and on the basis of the clinic of the Department of internal animal diseases and clinical diagnostics of Stepan 
Gzhytskyi National University of Veterinary Medicine and Biotechnology Lviv during 2018–2019. The objects 
consisted of 46 dogs with a confirmed diagnosis of myxomatous mitral valve disease according to the recommen-
dations of the American College of Veterinary Internal Medicine (ACVIM) and no signs of comorbidities. During 
the study, three experimental groups of animals were formed according to the clinical and functional status charac-
teristic of each stage of MMVD development – B1, B2, C. According to the results, all experimental dogs showed 
changes in the mitral apparatus in the form of thickening of the anterior and posterior cusps, mitral valve (MV) 
prolapse into the left atrial (LA) cavity and regurgitation (MR), the severity of which increased with the stage of 
the disease (from 20 % to 60 %). In 44.4 % of animals in group B2, thickening of the left ventricular walls was 
diagnosed in diastole and in 22.2 % in systole. Instead, these values increase to 46.1 % and 53.8 % in group C, 
respectively. However, the degree of hypertrophy is disproportionate. With the development of the disease, we 
detect its decrease from 0.64 ± 0.03 (group B1) to 0.50 ± 0.04 (group B2) and 0.51 ± 0.03 (group C) also we 
observed an increase in LVEDD/2 from 1.30 ± 0.05 cm (group B1) to 1.46 ± 0.12 cm (group B2) and 1.54 ± 0.13 
cm (group C). The value of nLVEDD in B1 was 1.36 times (P < 0.001) lower compared to B2 and C. Higher 
values of this parameter were found in 23.1 % of dogs in group C compared to the maximum value of B2. As MV 
insufficiency progresses, the LA/Ao index increases slightly (1.08 times) in B2, followed by an increase in C (1.38 
times, P < 0.001). At the same time, we diagnose an increase (P < 0.05) in PV/PA by 1.18 times in B2 and 1.46 
times (P < 0.001) in C. Thus, an increase in the severity of mitral regurgitation, a rapid increase in nLVEDD, the 
dynamics of the decrease in the degree of hypertrophy h/R, as well as an increase in LA/AO, PV/PA indices are 
predictors of unfavorable prognosis of myxomatous degeneration of the mitral valve in dogs. 
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Atrioventricular valve endocardiosis occurs in 75 % of 
cases of acquired cardiovascular diseases of dogs (Borgarelli 
& Buchanan, 2012; Lopez-Alvarez et al., 2015; Merveille et 
al., 2015; Ramírez et al., 2016). According to various au-
thors (Fox, 2012; Borgarelli & Buchanan, 2012; Chetboul & 
Tissier, 2012), the proportion of myxomatous mitral valve 
(MV) degeneration is 14–62 % (Yudina & Rybkova, 2019; 
Keene et al., 2019), and the incidence and progression are 
closely related to age, breed, and sex (Fox, 2012; Borgarelli 
et al., 2004). According to studies (Fox, 2012; Borgarelli & 
Buchanan, 2012; Chetboul & Tissier, 2012; Sargent et al., 
2015; Keene et al., 2019; Morgan et al., 2020), this disease 
is characterized by degenerative changes in the mitral appa-
ratus, changes in the morphology of the valve (increase in 
length, spherization, and loss of saddle shape of the mitral 
valve annulus, lengthening and increasing the area of the 
anterior cusp) (Menciotti et al., 2017), development of valve 
insufficiency, prolapse, regurgitation (MR), volume over-
load of the heart chambers, left atrial (LA) and left ventricu-
lar (LV) remodeling, and in the later stages – congestive 
heart failure (CHF), which leads to death in a third of cases 
(Merveille et al., 2015). Left atrial rupture and rupture of 
chordae tendineae are the most common complications of 
this disease (Fox, 2012; Borgarelli & Buchanan, 2012). 
Diagnosis of MMVD is complicated by the chronic 
course and long-term preclinical stage. However, to date, 
clear criteria have been developed for the detection of this 
pathology, based on in vivo assessment of morphological 
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changes by echocardiography (Chetboul & Tissier, 2012; 
Toaldo et al., 2016). A positive correlation was established 
between the severity of mitral valve prolapse and the degree 
of regurgitation with increasing CHF class (ISACHC class). 
Evaluation of the latter is important because it directly re-
flects the hemodynamic result of incomplete coaptation of 
the MV cusps during systole (Chetboul and Tissier, 2012). 
Such indicators of systolic function as fractional shortening 
(FS) and ejection fraction (EF) with the MMVD progression 
from ISACHC I to ISACHC III class remain within the 
reference range of 30–49 % and 55–75 %, respectively 
(Borgarelli et al., 2007; Chetboul & Tissier, 2012). The 
severity and incidence of pulmonary hypertension (PH) also 
increase with the MMVD progression (prevalence of 27 % 
ISACHC I, 72 % ISACHC III). However, it should be noted 
that it can be detected in the early stages of the disease 
(ISACHC Ia, ISACHC Ib) if moderate to severe MR ac-
companies MMVD (Chetboul & Tissier, 2012; Reynolds et 
al., 2012). The development of PH is a prognostic factor for 
survival in dogs with MMVD symptoms, as well as a sign of 
increased decompensation in asymptomatic animals  
(Chetboul & Tissier, 2012). 
At present, such issues as monitoring technique, 
predicting the course of MMVD, expansion of risk 
stratification schemes remain controversial. Therefore, the 
study aimed to evaluate the echocardiographic indices of left 
atrial and ventricular morphology, as well as to establish 
their diagnostic value in the MMVD progression in dogs. 
 
2. Materials and methods 
 
The study was conducted in a private veterinary hospital 
“Eurovet” and on the basis of the clinic of the Department of 
internal animal diseases and clinical diagnostics of Stepan 
Gzhytskyi National University of Veterinary Medicine and 
Biotechnology Lviv during 2018–2019. The study included 
46 dogs with mitral valve endocardiosis. The diagnosis was 
confirmed according to the criteria recommended by the 
American College of Veterinary Internal Medicine 
(ACVIM) (weight < 20 kg, left apical murmur, thickening 
and/or prolapse of MV leaflets in 2D mode, the presence of 
MR by color flow mapping (CFM), FS > 20 %, EF > 40 %) 
(Keene et al., 2019) and no signs of comorbidities. During 
the study, three experimental groups of animals were formed 
according to the clinical and functional status characteristic 
of each stage of MMVD development – B1 (group B1), B2 
(group B2) and C (group C) (according to the ACVIM clas-
sification). Group B1 consisted of 25 animals (10 males, 15 
females), age range was 7–14 (10.9 ± 0.47) years, body 
weight was in the range of 3.14–17.5 (8.4 ± 0.86) kg, the 
most common breeds were English Cocker Spaniel, mixed 
breed dogs, Yorkshire Terrier, Dachshund, Chihuahua, Pe-
kingese, Maltese, Miniature Pinscher, Papillon, Pug. Group 
B2 included 9 animals (6 males, 3 females) aged 7–18 
(11.1 ± 1.22) years and weighing 1.7–9.85 (4.8 ± 0.89) kg, 
among breeds were Pekingese, Dachshund, mixed breed 
dogs, Yorkshire Terrier, Chihuahua, Maltese. Group C in-
cluded 13 dogs (6 males, 7 females), age ranged from 8–15 
(11.8 ± 0.66) years, and body weight – 1.9–10.5 (5.3 ± 0.77) 
kg, breeds – Pekingese, Yorkshire Terrier, Miniature 
Schnauzer, mixed breed dogs, Dachshund, Miniature Poo-
dle, Beaver Yorkshire Terrier. Transthoracic echocardio-
graphic examination using 2 D, M-modes, pulse-wave (PW) 
Doppler, as well as color flow mapping (CFM) was per-
formed with Siemens (Acuson) S2000 and Esaote MyLab 
40 equipped with a 4–10 MHz and a 5–8.5 MHz phased-
array transducers, depending on the size of the animal. One 
ECG lead was recorded at a time. Fixation of animals was 
performed without the use of sedative pharmacological 
agents in the right and left lateral positions on a table with a 
cutout. Before the examination, the dogs were sheared in the 
sternal area and at the level of the costochondral junctions 
on both sides of the chest, and the skin surface was de-
greased with 70° ethanol, followed by a layer of acoustic 
gel. Qualitative images obtained from standardized projec-
tions were used to visualize cardiac structures and perform 
measurements (Thomas et al., 1994). The control data were 
the literature reference echocardiographic normal values 
according to the bodyweight of the object under study 
(Boon, 2017). For 2D-assessment of MV morphology 
(thickening, prolapse), the right parasternal four-chamber 
long axis view and the left four-chamber apical axis view 
were derived, and CFM-mode was used to detect and semi-
quantitatively assess (ARJ/LAA) the MR degree (Chetboul 
& Tissier, 2012). LV measurements in systole and diastole: 
interventricular septum (IVS), LV end-systolic dimension 
(LVESD), LV end-diastolic dimension (LVEDD), left ven-
tricular posterior wall (LVPW) were determined using M-
mode in the right parasternal short axis view at the level of 
papillary muscles, followed by indexation of LVESD, 
LVEDD according to body weight for a reliable assessment 
of cardiac remodeling (Cornell et al., 2004). The degree of 
hypertrophy was determined using the ratio h/R, where h is 
the thickness of LVPWd, and R = LVEDD/2 (Borgarelli et 
al., 2007). The ratio LA/Ao was calculated from the meas-
urements obtained in the right parasternal short axis view at 
the level of the aortic root in diastole, and PV/PA – the ratio 
of the pulmonary vein (PV) to the right branch of the pul-
monary artery (PA) obtained in the right parasternal four-
chamber long axis view at the end of the T wave. End-
diastolic volume (EDV), end-systolic volume (ESV) and 
ejection fraction were determined by a modified Simpson 
method. Five cardiac cycles were evaluated to derive the 
mean for each parameter. All calculations were performed 
with a PC, mathematical processing of the results was per-
formed using Microsoft Office Excel 2010 software accord-
ing to the generally accepted methods of variation statistics, 
with an estimate of the mean value (M), its margin of error 
(m). The significance was determined by Student's t-test. 
 
3. Results and discussion 
 
Results 
According to the anamnesis and clinical examination, 
groups B1 and B2 included animals in which no symptoms 
of the disease were detected at the time of the study. At 
auscultation of dogs in group B1, the left apical systolic 
murmur with the intensity of 1/6–2/6 was registered in 37 % 
of cases. In group B2, the prevalence of this type of murmur 
was 75 %, and the intensity increased to 3/6–4/6, in contrast 
to group C – 95 % with an intensity of 4/6–5/6, respectively. 
According to the results of the clinical study, the following 
was found in animals of the experimental group C: anemia 
of mucous membranes (61.5 %), cyanosis (15.4 %), in-
creased CRT (84.6 %), positive expiration reflex and cough-
ing (69.2 %), contouring of jugular veins (46.2 %), tachyp-
nea (76.9 %), tachycardia, prolonged noisy expiration 
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(76.9 %), fine moist rales (53.8 %), increase in abdominal 
volume (38,5 %). 
Changes in the mitral apparatus were diagnosed in all 
studied animals. In group B1, thickening of the anterior cusp 
(80 %), posterior (4 %), and both cusps (16 %), mild MR 
(ARJ/LAA < 20 %) have been detected. MV prolapse into 
the left atrial cavity was registered in 28 % of dogs. In group 
B2, the thickening of the anterior, both cusps were found in 
71 % and 29 %, respectively. There were moderate MR 
(ARJ/LAA ≥ 20–40 %) and signs of remodeling (hypertro-
phy of the left ventricular walls, LV chamber dilatation and 
LA enlargement). The direction of the regurgitation flow 
was lateral. In dogs of group C, MV changes are character-
ized by thickening of the anterior (46.2 %), posterior 
(7.6 %), and both cusps (46.2 %). MV prolapse (30.1 %) 
and posterior cusp prolapse (7.7 %) were established. Mod-
erate MR (ARJ/LAA ≥ 30–60 %) with hemodynamic effects 
of LA volume overload. The direction of MR flow is lateral 
(92.3 %) and medial (7.7 %). 
The main echocardiographic parameters of LV 
measurements are given in table 1. According to the 
assessment results of LV walls thickness in the systolic and 
diastolic phases, changes were found in each experimental 
group. We register a slight increase in IVSd, LVPWd, 
without changes in the values of IVSs and LVPWs in 20 % 
of B1 animals. In contrast, the number of B2 dogs with a 
moderate increase in diastolic measurements of LV walls 
thickness increases to 44.4 %. An increase in the thickness 
of IVS and LVPW in the systolic phase is recorded in 
22.2 %. In group C, 46.1 % of dogs showed thickening of 
the LV walls during diastole, and 53.8 % – during systole. 
In addition to determining the thickness of the walls, 
attention was also paid to the study of the degree of their 
hypertrophy with the MMVD progression. The results are 
presented in the form of diagram (Fig 1). 
 
Table 1 





Experimental group of animals 
В1 (n = 25) В2 (n = 9) С (n = 13) 
IVSd, cm 
Lim 0.43–1.11 0.46–0.97 0.46–1.15 
M ± m 0.7 ± 0.03  0.7 ± 0.06  0.7 ± 0.05 
LVEDD, cm 
Lim 1.6–3.55   2.1–4.24 1.48–4.89 
M ± m 2.6 ± 0.10  2.9 ± 0.23  3.1 ± 0.26 
nLVEDD, cm/kg 
Lim 1.13–1.69 1.71–2.18 1.06–2.54 
M ± m 1.4 ± 0.03  1.9 ± 0.06***  1.9 ± 0.10°°° 
LVPWd, cm 
Lim 0.51–1.15 0.48–1.20 0.55–1.06 
M ± m 0.8 ± 0.04  0.7 ± 0.07  0.8 ± 0.05 
IVSs, cm 
Lim 0.71–1.94 0.76–1.52 0.74–1.52 
M ± m 1.1 ± 0.06  1.0 ± 0.08  1.1 ± 0.06 
LVESD, cm 
Lim 0.92–1.98 1.11–2.23 0.65–2.91 
M ± m 1.4 ± 0.05  1.7 ± 0.11  1.4 ± 0.17 
nLVESD, cm/kg 
Lim 0.52–1.00 0.87–1.70 0.45–1.45 
M ± m 0.7 ± 0.02  1.1 ± 0.08***  0.9 ± 0.07° 
LVPWs 
Lim 0.8–1.66 0.81–1.8 0.89–1.88 
M ± m 1.2 ± 0.05  1.2 ± 0.11  1.3 ± 0.07 
Note: *** − P < 0.001 – significant difference compared to the parameters of group В1, ° – P < 0.05 – significant difference compared to the 
parameters of group В1, °°° – P < 0.001 – significant difference compared to the parameters of group В1 
 
 
Fig. 1. Box and whisker plot showing the radius of the LV cavity in diastole (R) and the ratio of the thickness of LVPWd (h) to 
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In sick dogs, the radius of the LV cavity in diastole in-
creases according to the progression of the MMVD stages 
from 1.30 ± 0.05 cm (group B1) to 1.46±0.12 cm (group B2) 
and 1.54 ± 0.13 cm (group C). At the same time, the degree 
of walls thickening with the development of the disease 
decreases from 0.64 ± 0.03 (group B1) to 0.50 ± 0.04 (group 
B2) and 0.51 ± 0.03 (group C). 
The analysis of the nLVEDD value in sick dogs revealed 
its probable changes. Thus, this indicator was 1.36 times 
(P < 0.001) lower in B1 animals compared to groups B2 and 
C, while in groups B2 and C a probable difference between 
the values was not found. However, higher nLVEDD values 
were found in 23.1 % of the experimental group C dogs 
compared to the maximum value in group B2. 
Similar changes were found when evaluating the 
nLVESD values. It is increased by 1.57 (P < 0.001) and 1.29 
(P < 0.05) times in experimental dogs of groups B2 and C, 
respectively, compared with the same indicator in group B1. 
When compared the values in groups B2 and C were ap-
proximate and did not differ statistically. This indicator is 
within the reference range in all three groups  
(1 ± 0.1 cm/kg). 
A study of end-systolic volume index (ESVI) values 
(Fig. 2) and functional parameters such as FS, EF (Fig. 3, 4) 
was also performed in the experimental groups of animals. 
The ESVI value in experimental group B1 was within the 
reference range (< 30 ml/m2). In group B2, we noted its 
increase (P < 0.001) in 1.97 times and in 33.3 % of dogs this 
determinant is higher than the upper limit value. At the same 
time, ESVI increases 1.61 times in group C compared to B1 
and it is 1.22 times lower than in group B2. 
The FS index in group B1 was in the range of 32–61 % 
and averaged 42.6 ± 1.16 % at the reference range of 30–
47 % (Fig. 3). Its increase was registered in 32 % of dogs. 
Similar changes are observed in group B2. The mean FS 
value was 44.3 ± 1.97 %, and an increase was found in 
33.3 % of experimental animals. The value of FS increases 
above normal in 76.9 % of dogs and averages 54.0 ± 3.02 % 
in group C in contrast to the other two experimental groups. 
When estimating EF (Fig.4) we found that the values of 
this parameter are higher than the norms (55–76 %) in group 
B1 (76.8 ± 1.67 %) and B2 (76.6 ± 1.97 %) and they are 
approximately the same. Alongside this, the EF value 
creases to 81.9 ± 3.45 % in group C. 
The LA/Ao ratio in dogs with MMVD progression was 
also evaluated (Fig. 5). 
This index was in the range of 1.02–1.42 (1.2 ± 0.02) in 
group B1, which corresponded to the reference values (1–
1.6). With the progression of MV insufficiency, there is a 
slight increase of 1.08 times in group B2 and 1.38 times 
(P < 0.001) in group C. 
In addition to the assessment of the LA to Ao ratio, an 
additional study of the ratio of pulmonary vein diameter 
(PV) to the diameter of the right branch of the pulmonary 




Fig. 2. Spot diagram of the ESVI values indexed to the body area of experimental animals with the progression of MMVD 
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Fig. 3. Spot diagram of the FS values of experimental animals with the progression of MMVD 
 
 
Fig. 4. Spot diagram of the EF values of experimental animals with the progression of MMVD 
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Fig. 5. Box and whisker plot of the LA/Ao ratio in early diastole with the development of MMVD, indicating the limits of each 
experimental group.            – P < 0.001 – significant difference compared to the parameters of group B2 
 
 
Figure 6. Horizontal Bar Chart of LA/Ao and PV/PA ratios in the development of MMVD with the indication of average  
values.   – P < 0.05 – significant difference compared to the parameters of group B1,         – P < 0.001 – significant difference 
compared to the parameters of group B2,           – P < 0.001 – significant difference compared to the parameters of group B2 
 
According to the obtained results, this indicator was 
within the reference range (0.8–1.7) in the first group of 
animals and averaged 1.1. We noted its increase (P < 0.05) 
in 1.18 times in group B2, but the values (0.9–1.6) did not 
exceed the reference limits. In group C, the ratio of PV/PA 
continued to increase (P < 0.001) and in 61.5 % of animals 
exceeded the reference values. We found a simultaneous 
proportional increase in LA/Ao and PV/PA with the MMVD 
progression (Fig. 6). 
 
Discussion 
Analyzing the age range of animals in the experimental 
groups, a clear increase in the mean value of age with the 
progression in the class of heart failure (HF) is observed, 
which is consistent with the literature. The cause of holosys-
tolic left apical murmur in dogs is the presence of regurgita-
tion blood flow in LA during systole. The development of 
clinical symptoms in animals of experimental group C is the 
result of the stage of decompensation, which is characterized 
in MMVD by a critical increase in preload, retrograde he-
mostasis in the pulmonary circulation, and the development 
of right heart failure with further progression. One of the 
links in the pathogenesis of MMVD is the presence of MR. 
It was found that even a semi-quantitative assessment of the 
general appearance of the regurgitation jet (size and depth of 
penetration into LA), as well as the morphology of MV, has 
prognostic value because the volume overload of the left 
heart increases with the progression of the above indicators 
associated with the appearance of clinical symptoms and 
deterioration of the HF class (Sargent et al., 2015; Larouche-
Lebel et al., 2019). 
An increase in nLVEDD values along with normal val-
ues or thickening of IVS and LVPW indicates remodeling of 
the LV cavity in the form of eccentric hypertrophy. The 
latter occurs due to MR, followed by an increase in volume 
overload with the HF progression in MMVD (Reynolds et 
al., 2012; Chetboul & Tissier, 2012; Ramírez et al., 2016). 
According to the results of the study, it should be noted that 
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a rapid increase in nLVEDD occurs immediately before the 
decompensation stage, i.e. in the experimental group B2 
(Chetboul & Tissier, 2012). The values of nLVESD and LV 
walls size in systole comprise the criteria for assessing myo-
cardial contractile function, and therefore the presence of 
these values within normal limits indicates the preservation 
of contractility. 
The change in LV walls thickness due to remodeling oc-
curs according to Laplace’s law, which helps to normalize 
the load on the wall during systole, but not during diastole 
(Borgarelli et al., 2007). In the settings of a progressive 
increase in chamber size due to volume overload during 
prolonged MR, we do not observe a corresponding directly 
proportional increase in wall thickness. Thus, the LVPW 
thickness in sick dogs does not differ significantly from 
animals in the preclinical stages, but their radius of the LV 
cavity is much larger, which reduces the h/R value. This fact 
has an unfavorable prognostic value because there will be a 
deterioration in systolic function in the later HF stages. 
Such echocardiographic determinants as ESVI, FS, and 
EF are indicators of myocardial systolic function. According 
to the literature (Borgarelli et al., 2007; Chetboul & Tissier, 
2012; Ramírez et al., 2016), we find differences in the opin-
ion of the authors regarding the contractility of the heart 
muscle. According to the results of studies (Borgarelli et al., 
2007; Chetboul & Tissier, 2012; Sargent et al., 2015; Ramí-
rez et al., 2016; Rudenko, 2018), there is a gradual  
increase in FS and EF in dogs with the MMVD progression 
and at first glance, it indicates not only the preservation of 
systolic capacity but also its increase. Such positive dynam-
ics represents the method of calculating these indices. FS 
and EF calculations depend on afterload, which is explained 
by a decrease in systolic and diastolic blood pressure  
(Ramírez et al., 2016), and preload, which increases with 
increasing degree of MR with the MMVD progression 
(Chetboul & Tissier, 2012; Sargent et al., 2015). Moreover, 
due to MV deficiency, an additional retrograde blood flow 
to the heart chamber with less resistance (left atrium) is 
created, which occurs faster than the opening of the aortic 
valve (Chetboul & Tissier, 2012). The hyperkinesis of IVS 
and LVPW seems to play also an important role in the 
growth of these functional parameters. Taking into account 
the above-mentioned facts, as well as the ESVI increase in 
sick dogs of groups B2 and C, we can conclude that the 
MMVD progression does reduce the true contractility of the 
LV myocardium, which is compensated at these stages by 
activation of the sympathoadrenal system and Frank-
Starling mechanism. 
Given the fact that the experimental groups included 
dogs with different body weights, in this study, we used the 
index of the LA/Ao ratio to estimate the LA size (Chetboul 
& Tissier, 2012). Its increase with each MMVD stage 
indicates an enlargement of the LA chamber due to volume 
overload, which occurs due to chronic and 
hemodynamically significant MR. It should be emphasized 
that in the initial asymptomatic stage, this phenomenon has 
a compensatory value because it prevents the development 
of hemostasis in the pulmonary circulation due to increased 
reserve capacity of LA. However, with further progression 
of the disease, subsequent dilatation of LA leads to a 
decrease in its functions (conductive, contractile) with 
retrograde hemostasis and the manifestation of clinical 
symptoms. Thus, LA enlargement is a negative prognostic 
sign in animals with MMVD (Schober et al., 2010; Chetboul 
& Tissier, 2012; Hollmer et al., 2017; Toaldo et al., 2018). 
An additional parameter for indirect assessment of pressure 
increase in LA is the size of the pulmonary vein diameter, 
which is determined by the following PV/PA ratio. The 
growth of the latter indicates a relative expansion of the 
vessel lumen due to increased pulmonary venous pressure, 
which in turn is a retrograde consequence of the increase in 
the LA pressure. The development of pulmonary venous 
stasis is a negative prognostic sign, which is a trigger factor 
for the development of pulmonary edema. Simultaneous 
direct proportional growth of LA/Ao and PV/PA with 
MMVD progression was also found. Thus, according to the 
results of our studies, the ratio of PV/PA is a predictor of the 
development of heart failure in dogs with MMVD with a 





During the echocardiographic examination of dogs with 
MMVD at different stages, we found that the increase in the 
severity of MR, the rapid increase in nLVEDD, the tendency 
of decreasing h/R, as well as increase of LA/AO, PV/PA 
indices are predictors of unfavorable prognosis of MMVD 
in dogs. Evaluation of such echocardiographic determinants 
as ESVI, FS, and EF had no significant prognostic value in 
the study. 
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